Salute e Benessere

Orexo enters into collaboration with Abera to develop nasal powder vaccines…

As a first step, the aim is to develop powder-based intranasal vaccine candidates, focusing on Abera's influenza vaccine candidate. An intranasal influenza vaccine has the potential to easily and effectively help reduce the spread of infections and prevent disease, which could play an important role in a potential future pandemic. As a first step, the aim is to develop powder-based intranasal vaccine candidates, focusing on Abera's influenza vaccine candidate. An intranasal influenza vaccine...
PR Newswire
17/12/2024

Invitation to presentation of Essity's report for quarter 4 and full year 2024

Contact information for conference call with the possibility to ask questions:UK: +44 (0) 33 0551 02 00 USA: +1 786 697 35 01SWE: +46 (0)8 505 204 24Please call in well in advance of the start of the presentation. Indicate: "Essity". Contact information for conference call with the possibility to ask questions: UK: +44 (0) 33 0551 02 00 USA : +1 786 697 35 01 SWE: +46 (0)8 505 204 24 Please call in well in advance of the start of the presentation. Indicate…
PR Newswire
17/12/2024

Press Release: Availability of the Q4 2024 Aide-mémoire

Availability of the Q4 2024 Aide-mémoireParis, France – December 17, 2024. Sanofi announced today that its Q4 2024 Aide-mémoire is available on the "Investors" page of the company's website:Fourth quarter & full year 2024 results (sanofi.com)As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder on various non-comparable items and exclusivity losses as well as the foreign...
Nasdaq GlobeNewswire
17/12/2024

Amai Proteins succesfully completed world's first human clinical trial on…

Although not required by regulatory authorities, Amai Proteins decided to conduct this study to boost consumer and market confidence in the safety and health profile of sweelin®. The study provides validated evidence of the beneficial effects of sweelin® on consumer's health. sweelin® can help consumers globally who are trying to reduce added sugars in their diet but don't want to compromise on taste or health. Although not required by regulatory authorities,Amai Proteins decided to conduct...
PR Newswire
17/12/2024

Sandoz takes further steps to resolve legacy US Generic Drug Antitrust Class…

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz takes further steps to resolve legacy US generic drug antitrust class action litigationSandoz US has entered into a settlement agreement with the class of end payer plaintiffs for USD 275 millionProvision of USD 265 million taken to cover potential additional settlement costs with regard to the US generic drug industry antitrust litigationNo impact on current Sandoz full-year 2024 and mid-term guidance...
Nasdaq GlobeNewswire
17/12/2024

CTLA-4 Inhibitors Market to Advance at Moderate CAGR During the Study Period…

Key Takeaways from the CTLA-4 Inhibitors Market Report Key Takeaways from the CTLA-4 Inhibitors Market Report Discover which therapies are expected to grab the CTLA-4 inhibitors market share @CTLA-4 Inhibitors Market Report CTLA-4 Inhibitors Market Dynamics In recent years, the CTLA-4 inhibitors market has been shaped by significant advances in cancer immunotherapy. Thegrowing use of combination therapies, particularly the pairing of CTLA-4 inhibitors withPD-1/PD-L1...
PR Newswire
16/12/2024

Jazz Pharmaceuticals Announces CEO Succession Plan

Board Will Lead Comprehensive Internal and External Search for New CEO; Intended to be Completed in 2025 Board Will Lead Comprehensive Internal and External Search for New CEO; Intended to be Completed in 2025 DUBLIN , Dec. 16, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced thatBruce Cozadd, Co-Founder, Chairperson and Chief Executive Officer (CEO), has informed the Board of Directors of his intent to retire from his role as CEO upon appointment of...
PR Newswire
16/12/2024

EssilorLuxottica signs an agreement to acquire Espansione Group for accelerating…

EssilorLuxottica signs an agreement to acquire Espansione Group for accelerating its growth in the med-tech spaceEssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases Paris, France (16 December 2024) – EssilorLuxottica announces that it has entered into an agreement for the acquisition of Espansione Group, an Italy-based company specialized in the...
Nasdaq GlobeNewswire
16/12/2024

DID YOU HAVE A HIP, KNEE, OR OTHER JOINT REPLACEMENT?

WHAT IS THIS ABOUT? WHAT IS THIS ABOUT? Exactech, Inc. designs, manufactures and markets joint replacement implants and other related surgical instruments. Exactech, Inc. and its affiliates have filed voluntary petitions for Chapter 11 relief inthe United StatesBankruptcy Court for the District ofDelaware. As a part of the proceedings, the Debtors will sell all, or nearly all, of their assets. If you received an implant, replacement, or other device from Exactech, your rights...
PR Newswire
16/12/2024

Vaccine Adjuvants Market to Hit USD 0.96 Billion by 2029 with 6.5% CAGR |…

Browse in-depth TOC on "Vaccine Adjuvants Market"490 - Tables50 - Figures388 - Pages Browse in-depth TOC on "Vaccine Adjuvants Market" 490 - Tables 50 - Figures 388 - Pages The product segment is further segmented into emulsion-based adjuvants, pathogen components, saponin-based adjuvants, particulate-based adjuvants, and others. The emulsion-based adjuvants dominated the market in 2023 owing to versatility in antigen platforms, scalability, and manufacturing feasibility, and…
PR Newswire
16/12/2024

Veterinary Diagnostics Market Anticipated to Lead the Way in Innovative…

IMR
16/12/2024

World's 1st Stem Cell Book on Animals, Reveals How to Extend the Lives of Pets

According to Prof. Chan, stem cells, the body's primary building blocks, are essential for regenerating damaged tissues and maintaining organ function. As animals age, the depletion of stem cells accelerates the aging process, leading to a decline in health and organ function. The book emphasizes that this depletion is one of the primary causes of aging. According to Prof. Chan, stem cells, the body's primary building blocks, are essential for regenerating damaged tissues and maintaining…
PR Newswire
16/12/2024

Linus Health Earns Medical Device Regulation Certification in the European Union

"The growth of dementia is a significant public health problem across the world," said Linus Health Chief Medical Officer Alvaro Pascual-Leone, MD, PhD. "Earning EU class IIa MDR certification allows us to expand our offering in the EU beyond assessment to include clinical decision support, which is critical in supporting clinicians to navigate next steps, consider concrete actionable recommendations, and connect patients with the right care and clinical interventions that have…
PR Newswire
16/12/2024

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 16 December 2024– On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024.Under…
Nasdaq GlobeNewswire
16/12/2024

Endo Announces Publication of Peyronie's Disease Self-Assessment Screening App…

The article details the purpose of the PD app, involvement from healthcare providers in the development of the tool and various features of the app, including image scans, a self-assessment questionnaire and provider locator. The article details the purpose of the PD app, involvement from healthcare providers in the development of the tool and various features of the app, including image scans, a self-assessment questionnaire and provider locator. "Development of a new Peyronie's disease...
PR Newswire
16/12/2024

Glow up this holiday with Ulike's biggest sale of the year

Glow into the holiday season with the Air 3 Deluxe, the ultimate self-care companion for smooth, radiant skin. Designed for convenience and luxury, this premium at-home IPL device helps you achieve long-lasting smooth skin at home. Its advanced Sapphire Ice Cooling Technology ensures a nearly painless treatment, keeping your skin cool and comfortable, even in sensitive areas. Glow into the holiday season with theAir 3 Deluxe, the ultimate self-care companion for smooth, radiant skin...
PR Newswire
16/12/2024

Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and…

These new additions complement Brains Bio's current portfolio, with the CBD API being used in over 30 clinical and pre-clinical studies, including a completed Phase III Refractory Epilepsy Study – submitted for Marketing Authorisation - and a Phase II Opioid Use Disorder Study. With immediate global sample distribution, Brains Bio unlocks new avenues for clinical research, product development, and therapeutic innovation. Unveiling the Next Wave of Cannabinoid-Based TherapiesBrains Bio's...
Nasdaq GlobeNewswire
16/12/2024

HKBU biologists discover two new windowpane shell species

Translucent silvery windowpane shells Translucent silvery windowpane shells Windowpane shells are edible but valued more for their shells which have been used for thousands of years as a substitute for glass. These beautiful translucent shells have been widely used in making windows, jewellery and decorative items such as lampshades and chandeliers. The HKBU biologists discovered the new speciesPlacuna aestuariafromHong Kong. The name " aestuaria " is derived from the Latin...
PR Newswire
16/12/2024

NeoPhore appoints Michael Shih as Chief Executive Officer

Robert James, Chairman of the Board, NeoPhore, said: "Michael joins at an exciting stage in NeoPhore's development having raised a significant Series B financing round which was supported by Bristol Myers Squibb. As we move closer to being a clinical Company Michael's experience as a corporate development leader in pharma and biotech will be instrumental in driving NeoPhore's next phase of growth." Robert James, Chairman of the Board, NeoPhore, said : "Michael joins at an exciting…
PR Newswire
16/12/2024

KT&G Establishes Eurasian Production Hub in Kazakhstan

In October 2023, KT&G held a groundbreaking ceremony for the new plant in Almaty, Kazakhstan, and began building a "hybrid production base" for overseas sales on a site of about 200,000 square meters. When the plant is completed in 2025, Kazakhstan will become a production hub for supplying products to Europe, the CIS, and the rest of Eurasia. InOctober 2023, KT&G held a groundbreaking ceremony for the new plant inAlmaty, Kazakhstan, and began building a "hybrid production…
PR Newswire
16/12/2024

Inventiva secures €21.4 million and completes the first tranche of the…

Inventiva secures €21.4 million leading to completion of the first tranche of the financing for c. €116 million, part of the multi-tranche equity financing of up to €348 million announced on October 14, 2024. Proceeds from the completed first tranche to be primarily used to advance Inventiva's Phase III, NATiV3 clinical trial evaluating lanifibranor in patients with MASH. Appointment of Mark Pruzanski as new Chairman of the Board of Directors and Srinivas Akkaraju as...
Nasdaq GlobeNewswire
16/12/2024

Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine…

Tech transfer of MVA-BN ®will help increase global mpox vaccine manufacturing capacity and further expand the equitable access to vulnerable populations.Serum Institute of India obtains license to MVA-BN for the Indian market.COPENHAGEN, Denmark, December 16, 2024– Bavarian Nordic A/S (OMX: BAVA) announced today a license and manufacturing agreement for its MVA-BN ®mpox vaccine with Serum Institute of India Pvt. Ltd. (“SII”). Under the agreement, the companies will undertake a...
Nasdaq GlobeNewswire
16/12/2024

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense…

Bagsværd, Denmark, 16 December 2024– Today, Novo Nordisk announced plans to invest 8.5 billion Danish kroner to establish a completely new production facility in Odense, Denmark. The investment marks the first time in this century that Novo Nordisk breaks ground in Denmark by establishing a new production site. The new site will feature a state-of-the-art finished production facility and warehouse spanning over 40,000 m 2. Designed to be modular and flexible, it will accommodate...
Nasdaq GlobeNewswire
16/12/2024

Basilea announces agreement with Innoviva Specialty Therapeutics for the…

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, December 16, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it has entered into an exclusive distribution and license agreement with Innoviva Specialty Therapeutics, Inc., a wholly owned subsidiary of Innoviva Inc. (NASDAQ: INVA), for the commercialization of...
Nasdaq GlobeNewswire
16/12/2024
Altri  Comunicati